Search
for
Sort by
Research 61–90 of 493
- Vellus hair cysts presenting as an atypical acneiform eruption
- Acne and acneiform eruptions
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- When bugs and drugs conspire: driving acneiform skin toxicity
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- Sorafenib-induced Facial Acneiform Eruption
- Erlotinib induced acneiform eruption: A case report
- Acneform eruptions with use of minoxidil-a case report
- Incidence of acneform reactions after laser hair removal
- Sorafenib-Associated Facial Acneiform Eruption
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Cyclophosphamide-associated acneiform drug eruption in a patient with multiple myeloma
- A Sterile Folliculocentric Acneiform Eruption Mimicking Infection After Hair Transplantation: Clinical Pattern Recognition and a Proposed FUE Epidermal Cap–Angle Mechanism
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Drug-induced acne
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Cutaneous side-effects of EGFR inhibitors and their management.
- Incidence and management of cutaneous toxicities associated with cetuximab
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study
- Difficult and rare forms of acne
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy